JP2017517567A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517567A5
JP2017517567A5 JP2017513597A JP2017513597A JP2017517567A5 JP 2017517567 A5 JP2017517567 A5 JP 2017517567A5 JP 2017513597 A JP2017513597 A JP 2017513597A JP 2017513597 A JP2017513597 A JP 2017513597A JP 2017517567 A5 JP2017517567 A5 JP 2017517567A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
optionally substituted
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017513597A
Other languages
English (en)
Japanese (ja)
Other versions
JP6823588B2 (ja
JP2017517567A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/031631 external-priority patent/WO2015179441A2/en
Publication of JP2017517567A publication Critical patent/JP2017517567A/ja
Publication of JP2017517567A5 publication Critical patent/JP2017517567A5/ja
Application granted granted Critical
Publication of JP6823588B2 publication Critical patent/JP6823588B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017513597A 2014-05-20 2015-05-19 大環状広域スペクトル抗生物質 Active JP6823588B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462000980P 2014-05-20 2014-05-20
US62/000,980 2014-05-20
US201562142404P 2015-04-02 2015-04-02
US62/142,404 2015-04-02
PCT/US2015/031631 WO2015179441A2 (en) 2014-05-20 2015-05-19 Macrocyclic broad spectrum antibiotics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021002243A Division JP7148652B2 (ja) 2014-05-20 2021-01-08 大環状広域スペクトル抗生物質

Publications (3)

Publication Number Publication Date
JP2017517567A JP2017517567A (ja) 2017-06-29
JP2017517567A5 true JP2017517567A5 (enExample) 2018-07-12
JP6823588B2 JP6823588B2 (ja) 2021-02-03

Family

ID=54554959

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017513597A Active JP6823588B2 (ja) 2014-05-20 2015-05-19 大環状広域スペクトル抗生物質
JP2021002243A Active JP7148652B2 (ja) 2014-05-20 2021-01-08 大環状広域スペクトル抗生物質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021002243A Active JP7148652B2 (ja) 2014-05-20 2021-01-08 大環状広域スペクトル抗生物質

Country Status (10)

Country Link
US (1) US10392422B2 (enExample)
EP (1) EP3145944B1 (enExample)
JP (2) JP6823588B2 (enExample)
KR (1) KR20170027721A (enExample)
CN (1) CN106661084B (enExample)
BR (1) BR112016027232A2 (enExample)
CA (1) CA2949681A1 (enExample)
MX (1) MX2016015218A (enExample)
RU (1) RU2016146581A (enExample)
WO (1) WO2015179441A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
KR20170027721A (ko) 2014-05-20 2017-03-10 알큐엑스 파마슈티컬스, 인크. 마크로시클릭 광범위 항생제
US11072635B2 (en) 2015-11-20 2021-07-27 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
TWI725075B (zh) * 2015-11-20 2021-04-21 美商Rqx製藥公司 巨環廣效抗生素
KR20180100570A (ko) * 2016-01-13 2018-09-11 제이에스알 가부시끼가이샤 감방사선성 수지 조성물, 레지스트 패턴 형성 방법, 산 확산 제어제 및 화합물
EP3426674A4 (en) 2016-03-09 2019-08-14 Blade Therapeutics, Inc. CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2017156074A1 (en) * 2016-03-09 2017-09-14 Blade Therapeutics, Inc. Calpain modulators and methods of production and use thereof
EP3481835A4 (en) 2016-07-05 2020-02-26 Blade Therapeutics, Inc. CALPAIN MODULATORS AND THEIR THERAPEUTIC USES
US10934261B2 (en) 2016-09-28 2021-03-02 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
EP3330260A1 (en) * 2016-12-01 2018-06-06 Enantia, S.L. Process for the preparation of an intermediate for the synthesis of i.a. carfilzomib
ES2979245T3 (es) * 2017-02-15 2024-09-25 Rqx Pharmaceuticals Inc Antibióticos macrocíclicos de amplio espectro
WO2018175173A1 (en) * 2017-03-21 2018-09-27 The Scripps Research Institute Cu-and ni-catalyzed decarboxylative borylation reactions
CN106966947B (zh) * 2017-03-30 2019-09-03 河北医科大学 一种维格列汀的制备方法
KR20240025066A (ko) * 2017-12-15 2024-02-26 메르크 파텐트 게엠베하 유기 전계 발광 디바이스용 치환된 방향족 아민
CN108806787B (zh) * 2018-07-06 2022-04-05 上海长海医院 面向临床手术的医用耗材智能监控系统
CN109355404B (zh) * 2018-08-30 2022-03-29 华南理工大学 基于聚合酶螺旋反应恒温检测单增李斯特菌的引物、试剂盒及检测方法
WO2020061244A2 (en) * 2018-09-19 2020-03-26 Georgia Tech Research Corporation Self-titrating bacterial protease-activated prodrug
US11208387B2 (en) * 2019-05-28 2021-12-28 Genentech, Inc. Macrocyclic broad spectrum antibiotics
CN118063337B (zh) * 2024-02-19 2025-01-28 绵阳师范学院 一种(s)-3-氨基-2-戊酮盐酸盐的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128280A (en) 1959-10-23 1964-04-07 Searle & Co 1-(alkoxylated/halogenated phenyl)-3-pyridylmethylureas
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB9902399D0 (en) 1999-02-03 1999-03-24 Smithkline Beecham Plc Compounds
US6660832B1 (en) 1999-08-20 2003-12-09 Isis Pharmaceuticals, Inc. Macrocyclic compounds and preparation methods thereof
US6951840B2 (en) * 2001-08-31 2005-10-04 Eli Lilly And Company Lipoglycopeptide antibiotics
DE10226921A1 (de) 2002-06-17 2003-12-24 Bayer Ag Antibakterielle Amid-Makrozyklen
NZ544750A (en) 2003-07-17 2009-06-26 Migenix Inc Compositions of amphomycin or aspartocin based lipopeptide antibiotic derivatives and methods of use thereof
DE10358824A1 (de) * 2003-12-16 2005-07-21 Bayer Healthcare Ag Antibakterielle Makrozyklen mit substituiertem Biphenyl
DE102005014247A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen VI
DE102005014245A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen V
JP2013522171A (ja) 2010-03-01 2013-06-13 ミレクシス, インコーポレイテッド 化合物およびその治療用途
BR112012021931A2 (pt) * 2010-03-09 2016-05-31 Merck Canada Inc composto, composição farmacêutica, método para tratar uma infecção bacteriana, e, uso de composto
US20130130985A1 (en) 2010-04-01 2013-05-23 Paul Alewood Oxytocin peptide analogues
RU2013112483A (ru) 2010-09-15 2014-10-20 Дзе Скриппс Рисеч Инститьют Аналоги ариломицина, представляющие собой антибиотики широкого спектра действия
US20140249073A1 (en) 2011-05-27 2014-09-04 Rqx Pharmaceuticals, Inc Broad spectrum antibiotics
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
WO2013138187A1 (en) 2012-03-14 2013-09-19 The Scripps Research Institute Broad spectrum antibiotic arylomycin analogs
CN103788176A (zh) 2012-10-31 2014-05-14 上海来益生物药物研究开发中心有限责任公司 一种arylomycin类化合物及其制备方法和应用
JP6437443B2 (ja) * 2012-11-21 2018-12-12 アールキューエックス ファーマシューティカルズ,インク. 大環状広域抗生物質
KR20170027721A (ko) 2014-05-20 2017-03-10 알큐엑스 파마슈티컬스, 인크. 마크로시클릭 광범위 항생제
ITUB20154591A1 (it) 2015-10-12 2017-04-12 Crestoptics S R L Apparato di microscopia confocale e relativo procedimento di acquisizione ed elaborazione di immagini
TWI725075B (zh) 2015-11-20 2021-04-21 美商Rqx製藥公司 巨環廣效抗生素
US11072635B2 (en) 2015-11-20 2021-07-27 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics

Similar Documents

Publication Publication Date Title
JP2017517567A5 (enExample)
JP2016501864A5 (enExample)
RU2016146581A (ru) Макроциклические антибиотики широкого спектра действия
JP2016528257A5 (enExample)
RU2016107436A (ru) Линейные пептидные антибиотики
JP2019527196A5 (enExample)
RU2018122505A (ru) Макроциклические антибиотики широкого спектра действия
SI2344129T1 (en) AEROSOL FLUOROKINOLONAL FORMULATIONS FOR IMPROVED PHARMACOKINETICS
ME02562B (me) Aerosolizovani fluorohinoloni i njihove upotrebe
RU2013104951A (ru) Циклические бороновые кислотно-эфирные производные и их использование в терапии
RU2018122498A (ru) Макроциклические антибиотики широкого спектра действия
JP2019502659A5 (enExample)
FI3986419T3 (fi) Boorihappojohdannaisia ja niiden terapeuttisia käyttöjä
JP2022137011A5 (enExample)
CA2504448A1 (en) Transcription factor modulating compounds and methods of use thereof
JP2019501123A5 (enExample)
JP2020510044A5 (enExample)
JP2019520417A5 (enExample)
RU2012111458A (ru) Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
JP2020505395A5 (enExample)
JP2009541332A5 (enExample)
JPWO2020061101A5 (enExample)
JP2020507564A5 (enExample)
JP2016506959A5 (enExample)
RU2009121808A (ru) СОЕДИНЕНИЯ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЗАИМОДЕЙСТВИЯ БЕЛКОВ Bcl С ПАРТНЕРАМИ СВЯЗЫВАНИЯ